Business

Eli Lilly Stock: Obesity-Drug Giant Approaches New Buy Point

Published

2 hours ago

12 August 2026

NewsAdmin

Obesity-drug leader Eli Lilly (LLY) is within striking distance of a new buy point following a strong quarterly earnings report. That makes Eli Lilly stock Wednesday’s pick for IBD 50 Growth Stocks To Watch from Investor’s Business Daily. The company develops and sells medicines across diabetes, obesity, immunology, oncology and neuroscience. Eli Lilly stock boasts an ideal score of 99…

Leave a Reply
Cancel reply

You must be logged in to post a comment.

Fashion5 days ago

Weekend Open Thread: Mattifying Sunscreen
Fashion5 days ago

Frugal Friday’s Workwear Report: Cap-Sleeve Pointelle Crewneck Sweater
News Videos4 days ago

Can Astrology Help Find Gold and Silver Trends? A Financial Astrology Guide
Sports7 days ago

Jordan Coyle & Cordiamo take Laya Arena Stakes at RDS
Business7 days ago

US stocks: Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq
Politics6 days ago

Reform UK And Greens Sink To Lowest Favourability Ratings To Date

WordUp News

Business

Eli Lilly Stock: Obesity-Drug Giant Approaches New Buy Point

Leave a Reply
Cancel reply

Leave a Reply

Trending

Leave a Reply Cancel reply

Leave a Reply

Trending

Leave a Reply
Cancel reply